Mortality over four years in SHEP participants with a low ankle-arm index

Journal of the American Geriatrics Society

Volumn 45, Issue 12, 1997, Pages 1472-1478

  Neivman, Anne B ^a,c   Tyrrell, Kirn Sntton ^a   Kuller, Lewis H ^b  

^a Division of Geriatric Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANKLE; ARM; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HUMAN; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0030862355     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03198.x     Document Type: Article

References (25)

1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug therapy in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
2. Mautner GC, Mautner SL, Roberts WC. Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol 1992;170:1147-1151.
3. Kannel WE, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. 1JJ Engl J Med 1984;311:1144-1147. ,
4. Autret A, Saudeau D, Bertrand PH, et al. Stroke risk in patients with carotid stenosis. Lancet 1987;1:888-890.
5. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;1 1:1245-1249.
6. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
7. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993;270:487-489.
8. Criqui MH, Fronek A, Barrett-Connor E et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-515.
9. Newman AB, Sutton KS, Rutan GH et al. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 1991;1:15-20.
10. Newman AB, Siscovick DS, Manolio TA. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-845.
11. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
12. Fowkes FGR, Housely E, Cawood EHH et al. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-392.
13. Vogt MT, Cauley JA, Newman AB et al. Decreased ankle/arm blood pressure index and mortality in elderly \vomen.JAMA 1993;270:465-469.
14. Schroll M, Munck D. Estimation of peripheral arterio-sclerotic disease by , ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981;34:261-269.
15. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42-48.
16. Kuller LH, Shemanski L, Psaty BM et al. Subclinical disease as an independent risk factor for cardiovasculardisease. Circulation 1995;92:720-726.
17. Sutton-Tyrrell K, Alcorn HG, Herzog H et al. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995;26:1319-1324.
18. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993;88(part 1):1444-1455.
19. Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: The importance of considering initial level of risk. Br MedJ 1993;306:1367-1373.
20. Pekkanen J, Linn S, Heis G et al. Ten-Year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990:322:1700-1707.
21. Witteman JCM, Grobbee DE, Valkenburg HA et al. Cigarette smoking and the development and progression of aortic atherosclerosis. Circulation 1993;88(part 1):2156-2162.
22. Tyrrell KS, Wolfson SK, Kuller LH. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994;25:44-50.
23. Pedersen TR, Kjekshus J, Berg K et al. Randomized trial of cholesterol lowing in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
24. Furberg CD, Manolio TA, Psaty BM et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol 1992;69:1329-1335.
25. Hirsch AT, Garg R, Elam JT et al. Quality-of-life and walking impairment in peripheral arterial disease in the arterial diseases multiple intervention trial. Circulation 1996;94:I-174.